Waveguide

WaveGuide, founded in Delaware and based in Cambridge, Massachusetts, focuses on developing portable micro-nuclear magnetic resonance (µNMR) technology for precise on-site chemical analysis. The company's core mission is to bring advanced scientific methods to the field, enabling conclusive decision-making at the point-of-care. Their flagship product, the WaveGuide Formµla™, is a portable NMR device capable of testing for oncology markers, pathogens, food and pharmaceutical purity, and more, making it ideal for diverse applications from intellectual property protection to infectious disease detection.

WaveGuide has garnered attention for its innovative approach to traditionally lab-bound NMR technology. The company has attracted notable investors and partners in the biotech and healthcare sectors, although specific names are not disclosed. Key achievements include the successful development and deployment of their portable NMR device in various field applications, significantly impacting on-site diagnostics and real-time analysis. WaveGuide's technology has the potential to revolutionize multiple industries by providing rapid, accurate testing capabilities outside traditional laboratory settings.